<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>VÃ©gran and colleagues proposed a model in which the <z:chebi fb="4" ids="24996">lactate</z:chebi> released from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells through MCT4 would be taken up by endothelial cells via the MCT1 transporter and stimulate <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, using human umbilical vein endothelial cells (HUVECs) as model of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> endothelial cells </plain></SENT>
<SENT sid="1" pm="."><plain>By analyzing a total of 505 cases of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples immunostained for MCT1, we do not confirm plasma membrane expression of MCT1 in the endothelial cells of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated vessels </plain></SENT>
</text></document>